# Taysha Gene Therapies, Inc. (TSHA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TSHA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -42.41M | $ -40.90M | $ 17.77M | $ 211.94M |
| 2025 | $ 10.01M | $ -111.60M | $ -96.07M | $ 18.17M | $ 246.94M |
| 2024 | $ 8.76M | $ -93.86M | $ -85.77M | $ 63.18M | $ 71.53M |
| 2023 | $ 16.71M | $ -120.63M | $ -86.92M | $ 61.11M | $ 74.94M |
| 2022 | $ 2.79M | $ -186.18M | $ -127.01M | $ 59.93M | $ 949.0K |
| 2021 | $ 0 | $ -207.45M | $ -164.74M | $ 63.09M | $ 95.38M |
| 2020 | $ 0 | $ -76.45M | $ -46.89M | $ 0 | $ 251.30M |
| 2019 | $ 0 | $ -1.44M | $ 0 | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.08 |
| Liabilities / Eq | 0.42 |
| Current Ratio | 14.04 |

## Other views

- [Metrics](https://sponda.capital/en/TSHA.md)
- [Charts](https://sponda.capital/en/TSHA/charts.md)
- [Compare](https://sponda.capital/en/TSHA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.